EUROFINS SCIENTIFIC: Contact: on track to outpace management's objectives | BUY | EUR77 vs. EUR710
EUROFINS SCIENTIFIC - BUY | EUR77 vs. EUR710 (+10%)Contact: on track to outpace management's objectives
Trading update: second lockdown taking a lesser toll…
…and IVD should largely drive Q4 growth as seen in Q3
Uncertainties but in all cases results should exceed management expectations
Resources for potentially actively taking over the M&A strategy
A win/win position whatever the scenario
Eurofins Scientific is an international life sciences company operating in food & pharmaceutical products testings. Co. provides analytical testing services to clients from various industries including pharmaceutical, food, and environmental sectors. Co. offers analytical methods for evaluating the authenticity, origin, safety, identity, composition, and purity of biological substances & products. Co. verifies authenticity of products analyzed to detect dangerous components (pathogens, prions, pesticides, asbestos, mycotoxins, dioxins, toxic substances, etc.). Co. operates in Benelux, France, Germany, North America, Scandinavia, British Isles (U.K. & Republic of Ireland), & other countries.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.